CorMedix
CRMD
68 hedge funds and large institutions have $42.5M invested in CorMedix in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 4 closing their positions.
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
92% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 12
79% more capital invested
Capital invested by funds: $23.7M → $42.5M (+$18.7M)
15% more funds holding
Funds holding: 59 → 68 (+9)
0.48% more ownership
Funds ownership: 25.32% → 25.79% (+0.48%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
59% less call options, than puts
Call options by funds: $502K | Put options by funds: $1.22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$311K |
| 2 |
Two Sigma Investments
New York
|
+$252K |
| 3 |
PD
Planning Directions
Glen Mills,
Pennsylvania
|
+$231K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$164K |
| 5 |
State Street
Boston,
Massachusetts
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$463K |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$306K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$98.9K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$77K |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$71K |
CRMD Hedge Fund Activity: Q2 2020 in Review
68 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2020, worth a combined $42.5M — up 79% from $23.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CRMD positions and 4 closed out — a net gain of 9 holders — while 23 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $311K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $463K sold.
- 68 institutional investors held CorMedix (CRMD) as of Q2 2020, up from 59 in Q1 2020.
- Funds reported $42.5M of CorMedix stock for Q2 2020, up 79% quarter-over-quarter.
- 13 funds opened new CorMedix positions in Q2 2020 and 4 closed out, a net change of +9 holders.
- The largest CorMedix buyer in Q2 2020 was BlackRock, an estimated $311K added.
- The largest CorMedix seller in Q2 2020 was Renaissance Technologies, an estimated $463K sold.
Based on aggregated 13F filings for Q2 2020.